Table 2.
Summary of meta‐analyses of studies using home visits to manage diabetes
| Outcome measure | Trails | Sample size (intervention/control) | Measure of effects | Intervention effect size (95% CI) | P‐value of effect | Heterogeneity | |
|---|---|---|---|---|---|---|---|
| I 2 (%) | P‐value | ||||||
| SBP (mmHg) | 2 | 109 (59/50) | MD | −5.94 (−11.34, −0.54) | 0.03* | 0 | 0.001 |
| DBP (mmHg) | 2 | 109 (59/50) | MD | −6.32 (−12.00, −0.65) | 0.03* | 48 | 0.001 |
| Quality of life | 2 | 186 (95/91) | SMD | 11.81 (7.20, 16.42) | 0.001** | 23 | 0.25 |
| High density lipoprotein (mg/dL) | 2 | 109 (50/59) | MD | −5.11 (−9.80, −0.43) | 0.03* | 0 | 0.4 |
| Low density lipoprotein (mg/dL) | 2 | 109 (50/59) | MD | −10.12 (−18.23, −2.00) | 0.01** | 0 | 0.75 |
| Weight (kg) | 2 | 123 (58/65) | MD | −5.06 (−12.61, 2.48) | 0.19 | 16 | 0.28 |
| Total cholesterol (mg/dL) | 2 | 109 (50/59) | MD | −4.06 (−18.28, 10.17) | 0.58 | 0 | 0.93 |
| Total triglycerides (mg/dL) | 2 | 109 (50/59) | MD | 50.72 (15.69, 85.75) | 0.005** | 0 | 0.51 |
| Body mass index (kg/m2) | 1 | 164 (72/92) | MD | 1 (−0.13, 2.13) | 0.08 | NA | NA |
| Self‐efficacy | 1 | 120 (56/74) | MD | −1.80 (−5.37, 1.77) | 0.32 | NA | NA |
| Self‐management | 1 | 120 (56/74) | MD | 0.70 (0.51, 0.89) | 0.001** | NA | NA |
*P < 0.05, **P < 0.01. Heterogeneity (I 2): <50% = low, 50–75% = moderate, >75% = high. CI, confidence intervals; MD, mean difference; NA, not applicable; SMD, standardized mean difference.